All Outputs (2)

Clinical presentation, treatment and outcome of canine malignant mesothelioma: A retrospective study of 34 cases (2021)
Journal Article
Larsen Moberg, H., Gramer, I., Schofield, I., Blackwood, L., Killick, D., Priestnall, L., & Guillén, A. (2022). Clinical presentation, treatment and outcome of canine malignant mesothelioma: A retrospective study of 34 cases. Veterinary and Comparative Oncology, 20(1), 304-312. https://doi.org/10.1111/vco.12777

Canine malignant mesothelioma (CMM) is a rare and aggressive tumour associated with a poor prognosis. Limited information is available regarding effective treatment options and prognostic factors. The purpose of this retrospective case series was to... Read More about Clinical presentation, treatment and outcome of canine malignant mesothelioma: A retrospective study of 34 cases.

Immunohistochemical expression and prognostic significance of MAGE-A in canine oral malignant melanoma (2021)
Journal Article
Guillén, A., Stiborova, K., Ressel, L., Blackwood, L., Finotello, R., Amores-Fuster, I., …Killick, D. (2021). Immunohistochemical expression and prognostic significance of MAGE-A in canine oral malignant melanoma. Research in Veterinary Science, 137, 226-234. https://doi.org/10.1016/j.rvsc.2021.05.009

Canine oral malignant melanoma (COMM) is considered a chemo-resistant cancer with a poor long-term prognosis. The melanoma-associated antigen A (MAGE-A) genes, which belong to the cancer-testis antigen family, are expressed in several different canin... Read More about Immunohistochemical expression and prognostic significance of MAGE-A in canine oral malignant melanoma.